Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2000
11/22/2000EP1053745A1 Use of at least a calcium-channel-inhibitor in the treatment of wrinkles
11/22/2000EP1053306A1 Secreted proteins and polynucleotides encoding them
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053233A1 Hydroxamic and carboxylic acid derivatives
11/22/2000EP1053221A2 Lipid mixtures and their use
11/22/2000EP1053029A1 Sterile complex of therapeutic peptide bond to a polysaccharide
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052963A1 Compositions and methods of treating keratin-related disorders and conditions
11/22/2000EP0701443B2 Terfenadine metabolites and their optically pure isomers for treating allergic disorders
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1273837A Black ointment
11/22/2000CN1273829A Medicinal composition for treating foot ringworm
11/22/2000CN1273827A Disinfecting liquid for treating tinea and pile
11/22/2000CN1273824A Exterior-applied medicine containing phosphonomycin calcium and its application
11/22/2000CN1273816A Activated and concentrated liquid containing minerals and race elements and preparing process thereof
11/22/2000CN1273815A Skin-protecting and beautifying liquid
11/22/2000CN1058724C Use of steroid compound for preparing medicaments
11/22/2000CN1058635C Oral medicine for treating beri-beri
11/22/2000CN1058631C 银屑病胶囊 Psoriasis capsules
11/22/2000CN1058627C Compound arnebia root paste for curing heat injury of human body and its preparing method
11/22/2000CN1058624C Burns curing powder and its prepn. method
11/22/2000CN1058619C Antiphlogistic analgesic ointment for treating burn
11/22/2000CN1058613C Ointment for resolving blood stasis and prepn. method
11/21/2000US6150557 Compounds
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150413 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders, as well as mammalian skin and hair conditions; 4-(4-(biphenyl-2-yl)but-3-en-1-ynyl)benzoic acid, for example
11/21/2000US6150407 In a tissue or organ by contacting with a compound of given formula such as methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate; reducing the level of tumor necrosis factor alpha
11/21/2000US6150403 Topical compositions for regulating the oily/shiny appearance of skin
11/21/2000US6150377 Farnesyl protein transferase inhibitors; anticarcinogenic,-tumor and -proliferative agents; also psoriasis, benign prostatic hypertrophy or restinosis; infections facilitated by farnesyl protein transferase, e.g., malaria or hepatitus delta
11/21/2000US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone
11/21/2000US6150373 Bicyclic nitrogen heterocycles
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/21/2000US6150359 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
11/21/2000US6150348 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
11/21/2000US6150346 Method and composition for treating or preventing osteoporosis
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150153 Thermostable trehalose-releasing enzyme
11/21/2000US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150101 Methods of identifying a composition that alters connective tissue growth factor expression
11/21/2000US6149947 Compositions of oak bark extract related synthetic compositions and method of using same
11/21/2000US6149925 Applying cosmetic or pharmaceutical composition comprising effective amounts of a glycine compound, a glutamine compound, and a sulfhydryl-containing organic acid, and carrier to skin
11/21/2000US6149924 For topical application
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068226A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000WO2000068223A1 Ureas and their use as cell adhesion modulators
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000WO2000068191A1 Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067791A1 Ccr4 antagonists in sepsis
11/16/2000WO2000067788A2 Use of soluble costimulatory molecules to enhance immune responses
11/16/2000WO2000067774A2 Materials for soft tissue augmentation and methods of making and using same
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067734A2 Use of phthalazine derivatives
11/16/2000WO2000067728A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000WO2000067626A2 Oat extracts: refining, compositions and methods of use
11/16/2000WO2000041669A3 Benzimidazole vascular damaging agents
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000038625A3 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000032180A3 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituted indolealkanoic acids
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000DE19921567A1 Verwendung von Phthalazine-Derivaten Use of derivatives phthalazines
11/16/2000DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000CA2373256A1 Use of soluble costimulatory molecules to enhance immune responses
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/16/2000CA2373010A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372704A1 Use of phthalazine derivatives
11/16/2000CA2371265A1 Materials for soft tissue augmentation and methods of making and using same
11/16/2000CA2369594A1 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/15/2000EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof
11/15/2000EP1051979A1 Use of peroxidised lipids to prevent and/or treat the irritating effect of an active agent
11/15/2000EP1051972A1 Nitric oxide donor composition and method for treatment of anal disorders
11/15/2000EP1051521A2 Method of screening therapeutic agents
11/15/2000EP1051490A2 Modulation of cell proliferation, methods and reagents
11/15/2000EP1051431A1 Thrombin inhibitors
11/15/2000EP1051410A1 Benzo[b]pyran derivatives useful as external agents for the skin
11/15/2000EP1051403A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/15/2000EP1051395A1 Hydroxamic and carboxylic acid derivatives
11/15/2000EP1051192A2 Methods for the prevention and treatment of fibrosis and sclerosis
11/15/2000EP1051157A2 Controlled release delivery of peptide or protein
11/15/2000EP1051150A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
11/15/2000EP1051142A1 A new powerful cosmetic or pharmaceutical composition
11/15/2000EP0923378A4 Promotion of wound healing by chemically-modified tetracyclines
11/15/2000CN1273239A (Poly) thia acetylenic acid and it derivative, composite containing them and its application
11/15/2000CN1273124A Powder prepared with colophony, realgar and 'Huangdan'
1 ... 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 ... 1065